Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
Phase 2 Completed
29 enrolled 15 charts
Doxil/Caelyx BE Study
Phase 1 Completed
36 enrolled
Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer
Phase 2 Completed
9 enrolled 10 charts
met-HEReMYTA
Phase 2 Completed
49 enrolled
ALICE
Phase 2 Completed
68 enrolled
ICON
Phase 2 Completed
82 enrolled
A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies
Phase 1 Completed
35 enrolled
Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative
Phase 2 Completed
17 enrolled 8 charts
Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
Phase 2 Completed
49 enrolled 16 charts
A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer
Phase 1 Completed
83 enrolled
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
Phase 3 Completed
1,925 enrolled 19 charts
Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients
Phase 4 Completed
288 enrolled
Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
Phase 1 Completed
7 enrolled
Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer
Phase 1/2 Completed
2 enrolled 1 chart
Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy
Completed
760 enrolled
Stop&Go
Phase 3 Completed
420 enrolled
A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)
Phase 2 Completed
27 enrolled 5 charts
Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer
Phase 1 Completed
45 enrolled
CAPRICE
Phase 2 Completed
50 enrolled
Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer
Phase 1/2 Completed
30 enrolled 13 charts
Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer
Phase NA Completed
100 enrolled
Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)
Phase 2 Completed
181 enrolled 9 charts
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
Phase 1 Completed
32 enrolled
Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin
Phase 2 Completed
32 enrolled 7 charts
Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer
Phase 1/2 Completed
45 enrolled 8 charts
A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer
Phase 1 Completed
54 enrolled
Caelyx Adjuvant in Elderly Breast Cancer
Phase 2 Completed
16 enrolled
A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)
Completed
167 enrolled 10 charts
A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer
Phase 3 Completed
751 enrolled 10 charts
Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast Cancer
Phase 1 Completed
23 enrolled
Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer
Phase 1 Completed
20 enrolled 9 charts
Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
Phase 2 Completed
102 enrolled 7 charts
Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer
Phase 1/2 Completed
107 enrolled
Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer
Phase 2 Completed
45 enrolled
Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer
Phase 2 Completed
67 enrolled